
Jehanne Souaya Sitton
Examiner (ID: 9654)
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1655, 1634, 1682 |
| Total Applications | 1444 |
| Issued Applications | 515 |
| Pending Applications | 318 |
| Abandoned Applications | 641 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18406152
[patent_doc_number] => 20230167503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES
[patent_app_type] => utility
[patent_app_number] => 18/160366
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18160366
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/160366 | METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES | Jan 26, 2023 | Pending |
Array
(
[id] => 18552471
[patent_doc_number] => 20230250481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES
[patent_app_type] => utility
[patent_app_number] => 18/160373
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18160373
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/160373 | METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES | Jan 26, 2023 | Pending |
Array
(
[id] => 18552471
[patent_doc_number] => 20230250481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES
[patent_app_type] => utility
[patent_app_number] => 18/160373
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18160373
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/160373 | METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES | Jan 26, 2023 | Pending |
Array
(
[id] => 19896817
[patent_doc_number] => 12274711
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-15
[patent_title] => Method of determining Acute Myeloid Leukemia response to treatment with farnesyltransferase inhibitors
[patent_app_type] => utility
[patent_app_number] => 18/147134
[patent_app_country] => US
[patent_app_date] => 2022-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 14103
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18147134
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/147134 | Method of determining Acute Myeloid Leukemia response to treatment with farnesyltransferase inhibitors | Dec 27, 2022 | Issued |
Array
(
[id] => 18485355
[patent_doc_number] => 20230212692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => METHOD FOR SORTING COLORECTAL CANCER AND ADVANCED ADENOMA AND USE OF THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/088405
[patent_app_country] => US
[patent_app_date] => 2022-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6756
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18088405
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/088405 | METHOD FOR SORTING COLORECTAL CANCER AND ADVANCED ADENOMA AND USE OF THE SAME | Dec 22, 2022 | Pending |
Array
(
[id] => 18485355
[patent_doc_number] => 20230212692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => METHOD FOR SORTING COLORECTAL CANCER AND ADVANCED ADENOMA AND USE OF THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/088405
[patent_app_country] => US
[patent_app_date] => 2022-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6756
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18088405
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/088405 | METHOD FOR SORTING COLORECTAL CANCER AND ADVANCED ADENOMA AND USE OF THE SAME | Dec 22, 2022 | Pending |
Array
(
[id] => 18436520
[patent_doc_number] => 20230183814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => PREDICTIVE BIOMARKERS FOR ONVANSERTIB TREATMENT
[patent_app_type] => utility
[patent_app_number] => 18/078615
[patent_app_country] => US
[patent_app_date] => 2022-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18078615
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/078615 | PREDICTIVE BIOMARKERS FOR ONVANSERTIB TREATMENT | Dec 8, 2022 | Pending |
Array
(
[id] => 18436520
[patent_doc_number] => 20230183814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => PREDICTIVE BIOMARKERS FOR ONVANSERTIB TREATMENT
[patent_app_type] => utility
[patent_app_number] => 18/078615
[patent_app_country] => US
[patent_app_date] => 2022-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18078615
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/078615 | PREDICTIVE BIOMARKERS FOR ONVANSERTIB TREATMENT | Dec 8, 2022 | Pending |
Array
(
[id] => 18436520
[patent_doc_number] => 20230183814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => PREDICTIVE BIOMARKERS FOR ONVANSERTIB TREATMENT
[patent_app_type] => utility
[patent_app_number] => 18/078615
[patent_app_country] => US
[patent_app_date] => 2022-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18078615
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/078615 | PREDICTIVE BIOMARKERS FOR ONVANSERTIB TREATMENT | Dec 8, 2022 | Pending |
Array
(
[id] => 18771214
[patent_doc_number] => 20230366028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => DIAGNOSIS OF INFLAMMATORY BOWEL DISEASE BASED ON GENES
[patent_app_type] => utility
[patent_app_number] => 18/063931
[patent_app_country] => US
[patent_app_date] => 2022-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26911
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063931
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/063931 | DIAGNOSIS OF INFLAMMATORY BOWEL DISEASE BASED ON GENES | Dec 8, 2022 | Pending |
Array
(
[id] => 18286804
[patent_doc_number] => 20230102276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => APTAMERS FOR THE REVERSIBLE INHIBITION OF DNA POLYMERASES
[patent_app_type] => utility
[patent_app_number] => 18/057614
[patent_app_country] => US
[patent_app_date] => 2022-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6238
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057614
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/057614 | APTAMERS FOR THE REVERSIBLE INHIBITION OF DNA POLYMERASES | Nov 20, 2022 | Pending |
Array
(
[id] => 18335874
[patent_doc_number] => 20230127823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => Non-Invasive Gene Mutation Detection in Lung Cancer Patients
[patent_app_type] => utility
[patent_app_number] => 17/931205
[patent_app_country] => US
[patent_app_date] => 2022-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13822
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931205
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/931205 | Non-Invasive Gene Mutation Detection in Lung Cancer Patients | Sep 11, 2022 | Pending |
Array
(
[id] => 18497795
[patent_doc_number] => 20230220485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => CANCER BIOMARKERS AND CLASSIFIERS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/929881
[patent_app_country] => US
[patent_app_date] => 2022-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66497
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929881
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/929881 | CANCER BIOMARKERS AND CLASSIFIERS AND USES THEREOF | Sep 5, 2022 | Pending |
Array
(
[id] => 18497795
[patent_doc_number] => 20230220485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => CANCER BIOMARKERS AND CLASSIFIERS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/929881
[patent_app_country] => US
[patent_app_date] => 2022-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66497
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929881
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/929881 | CANCER BIOMARKERS AND CLASSIFIERS AND USES THEREOF | Sep 5, 2022 | Pending |
Array
(
[id] => 18361657
[patent_doc_number] => 20230143248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => METHOD FOR DIRECT MICROBIAL IDENTIFICATION
[patent_app_type] => utility
[patent_app_number] => 17/892819
[patent_app_country] => US
[patent_app_date] => 2022-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8340
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17892819
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/892819 | METHOD FOR DIRECT MICROBIAL IDENTIFICATION | Aug 21, 2022 | Pending |
Array
(
[id] => 18242470
[patent_doc_number] => 20230074781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => METHODS AND COMPOSITION FOR THE PREDICTION OF THE ACTIVITY OF ENZASTAURIN
[patent_app_type] => utility
[patent_app_number] => 17/820772
[patent_app_country] => US
[patent_app_date] => 2022-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17820772
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/820772 | METHODS AND COMPOSITION FOR THE PREDICTION OF THE ACTIVITY OF ENZASTAURIN | Aug 17, 2022 | Abandoned |
Array
(
[id] => 18376021
[patent_doc_number] => 20230151103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => STROMAL GENE SIGNATURES FOR DIAGNOSIS AND USE IN IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/886809
[patent_app_country] => US
[patent_app_date] => 2022-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44273
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17886809
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/886809 | STROMAL GENE SIGNATURES FOR DIAGNOSIS AND USE IN IMMUNOTHERAPY | Aug 11, 2022 | Abandoned |
Array
(
[id] => 18164669
[patent_doc_number] => 20230031265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => DEVICES, METHODS AND COMPOSITIONS FOR APTAMER SCREENING
[patent_app_type] => utility
[patent_app_number] => 17/819051
[patent_app_country] => US
[patent_app_date] => 2022-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17819051
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/819051 | DEVICES, METHODS AND COMPOSITIONS FOR APTAMER SCREENING | Aug 10, 2022 | Pending |
Array
(
[id] => 18164669
[patent_doc_number] => 20230031265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => DEVICES, METHODS AND COMPOSITIONS FOR APTAMER SCREENING
[patent_app_type] => utility
[patent_app_number] => 17/819051
[patent_app_country] => US
[patent_app_date] => 2022-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17819051
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/819051 | DEVICES, METHODS AND COMPOSITIONS FOR APTAMER SCREENING | Aug 10, 2022 | Pending |
Array
(
[id] => 20116255
[patent_doc_number] => 12365948
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-22
[patent_title] => Diagnostic test for predicting metastasis and recurrence in cutaneous melanoma
[patent_app_type] => utility
[patent_app_number] => 17/883223
[patent_app_country] => US
[patent_app_date] => 2022-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4080
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17883223
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/883223 | Diagnostic test for predicting metastasis and recurrence in cutaneous melanoma | Aug 7, 2022 | Issued |